Ep 84: Merlin CP-GEP and Castle i31-SLNB tests

from Melanoma Matters · host Melanoma Matters Pod

In this episode, the chin dimple is front and center. James explains the wizarding home of Tintagel in Cornwall to Sapna, situated on a lovely promontory. This episode explores the latest evidence on gene expression profile tests—Merlin 001 study of CP-GEP and Castle i31-SLNB —used to predict sentinel lymph node positivity in melanoma. James and Sapna discuss the study designs, clinical utility, and implications for clinical management.

Episode metadata supplied by the publisher feed · Published Jul 24, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Ep 84: Merlin CP-GEP and Castle i31-SLNB tests

0:00 35:29

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Melanoma Matters?

This episode is 35 minutes long.

When was this Melanoma Matters episode published?

This episode was published on July 24, 2026.

Can I download this Melanoma Matters episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!